At Cornerstone Wellness, we understand the complexities surrounding cannabis use, particularly when it comes to mental health. Historically, the relationship between cannabis and schizophrenia has raised many concerns, with studies suggesting that cannabis use could exacerbate symptoms in vulnerable individuals. However, a new study highlighted by NORML challenges this narrative by showing that in regions where cannabis is legalized, hospitalizations among patients with schizophrenia have actually decreased. This suggests that legalization may lead to better care and symptom management, possibly due to increased access to regulated products and medical guidance. This shift highlights the need for ongoing research, and we remain committed to educating our community on responsible cannabis use and its evolving role in healthcare.
Read the NORML article here.
Are you old enough to be here?
Are you 21 or over?